The NHS is bracing for a crisis that has long been feared but never before confirmed: a bacterial infection impervious to every licensed antibiotic. Doctors at a London teaching hospital have identified a strain of Klebsiella pneumoniae that resisted all 26 antibiotics tested, including last-resort drugs like colistin and carbapenems. This is not a laboratory experiment. It is a patient who survived only because the infection was caught early and contained surgically.

For the working families I speak to in Bolton and Barnsley, this news may seem distant. But it is not. The rise of pan-resistant bacteria is a slow-moving disaster that will hit the poor hardest. Antibiotic resistance already claims 1.27 million lives globally each year. When these bugs become untreatable, routine operations like hip replacements and caesareans become deadly gambles. Chemotherapy becomes impossible. The cost will not be borne equally.

Dr. Alisha Patel, an infectious disease consultant at the hospital, told me this strain did not emerge from a lab. It evolved in a community where antibiotics are overused. The patient had no recent travel history and no known risk factors. “This is not a warning,” she said. “This is the event.”

The pharmaceutical industry has abandoned antibiotic development because it is not profitable enough. The last truly new class of antibiotics was discovered in the 1980s. Meanwhile, factory farms continue to dose healthy animals with antibiotics to speed growth, a practice banned in the EU but still legal here. The government promised a new antibiotic subscription model in 2020 to incentivise research, but progress has been glacial.

What does this mean for a nurse in Sheffield or a warehouse worker in Leicester? It means that a simple scratch from a rose bush could become untreatable. It means that the miracle of modern medicine is quietly unravelling. The NHS will have to decide who gets the last effective antibiotics. That decision will inevitably be influenced by the same forces that already widen the health gap between rich and poor.

The union that represents hospital pharmacists, the Guild of Healthcare Pharmacists, has called for a national antibiotic stewardship strategy with teeth. They want mandatory reporting of antibiotic use on farms and a public education campaign as urgent as the one against smoking. The Health Secretary has offered only vague reassurances about “monitoring the situation”.

I have reported on many things in my career: pit closures, zero-hours contracts, the winter fuel payment cut. But this story feels different. This is about whether our children will die of infections their grandparents shrugged off. The antibiotics wall is not a metaphor. It is a wall we built ourselves through greed and neglect. And now doctors are telling us we have reached the top.